US Broker Ratings

CVS Health Corporation (CVS) Stock Analysis: Unpacking an 18% Upside Potential for Investors

CVS Health Corporation (NYSE: CVS) is a major player in the healthcare sector, commanding a market capitalization of $100.82 billion. As a multifaceted healthcare company, CVS operates through three primary..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 21 Buy Ratings and a Promising Pipeline

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing the attention of investors with its innovative approach to tackling RAS-addicted cancers, a notoriously challenging area in oncology. With a market capitalization of..

Doximity, Inc. (DOCS) Stock Analysis: Evaluating a 55.64% Potential Upside in the Health Information Sector

As the healthcare industry continues to evolve, digital platforms like Doximity, Inc. (NYSE: DOCS) are playing an increasingly pivotal role. With a current market capitalization of $8.26 billion, Doximity stands..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a leading player in the healthcare sector, has captured investor attention with its innovative approach to cancer diagnostics and screening. With a market capitalization of..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Revenue Challenges

Avantor, Inc. (AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry, providing invaluable mission-critical products and services across a global landscape. With a..

Incyte Corporation (INCY): Analyst Ratings Highlight Growth Potential Amid Market Volatility

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is making headlines with its strong financial performance and promising pipeline of therapeutic products. With a market capitalization of..

Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with a 2.43% Potential Upside

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector, continues to be a significant player in the diagnostics and research industry. With a market capitalization of $22.94 billion, the..

Teva Pharmaceutical (TEVA) Stock Analysis: Exploring Growth Potential Amidst Robust Analyst Ratings

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a prominent player in the global pharmaceutical landscape, primarily recognized for its expansive portfolio of generic and specialty medicines. With a market capitalization..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Deep Dive into its 23.94% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a beacon of innovation in the healthcare sector, specifically within the biotechnology industry. With a robust market capitalization of $52.52 billion, this Massachusetts-based..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating the 5.61% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) continues to captivate the attention of investors as it stands at the forefront of the biotechnology industry with a robust portfolio and promising growth potential...

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant Poised for a 11.50% Upside

For investors seeking exposure in the healthcare sector, Cencora, Inc. (NYSE: COR) presents a compelling opportunity. Formerly known as AmerisourceBergen Corporation, the company rebranded as Cencora in August 2023, marking..

Encompass Health Corporation (EHC) Stock Analysis: A Compelling 31% Upside Potential with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, operates within the medical care facilities industry. Headquartered in Birmingham, Alabama, the company specializes in post-acute healthcare services,..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a 18.46% Potential Upside for Investors

Ascendis Pharma A/S (NASDAQ: ASND) is capturing the attention of investors, with its current financial metrics and strategic positioning in the biotechnology sector suggesting a promising potential upside of 18.46%...

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with 15% Upside Potential

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and promising future projections. With a market capitalization of $218.36..

Haleon plc (HLN) Investor Outlook: Analyzing the 21.95% Potential Upside

For investors eyeing opportunities in the healthcare sector, Haleon plc (NYSE: HLN) presents itself as a notable contender. With a market capitalization of $42.39 billion, this UK-based company is a..

Insmed Incorporated (INSM) Stock Analysis: Unveiling a 14% Potential Upside in the Biotech Sector

Insmed Incorporated (NASDAQ: INSM) stands as a compelling entity in the biotechnology sector, making waves with its innovative therapies targeting serious and rare diseases. Headquartered in Bridgewater, New Jersey, Insmed’s..

Alcon Inc. (ALC) Stock Analysis: Evaluating a 16.87% Potential Upside for Investors

Alcon Inc. (NYSE: ALC), a leader in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors with its robust market presence and promising growth..

Merck & Company, Inc. (MRK) Stock Analysis: Strong Buy Ratings and Potential 7.14% Upside

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, stands as a formidable player in the drug manufacturing industry. Boasting a robust market cap of $250.53 billion,..

The Cooper Companies, Inc. (COO) Stock Analysis: Navigating a 10.26% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, has long been a staple for investors looking to explore opportunities in medical instruments and supplies. With..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 24.28% Potential Upside in the Healthcare Sector

Baxter International Inc. (NYSE: BAX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $9.84 billion, Baxter..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds